NASDAQ:CLOV   Clover Health Investments, Corp.
Investors jumped the gun based on faulty short interest numbers from S3, anticipating a short squeeze. The recent rises in price were not due to a squeeze, simply impulsive investors still chasing the dragon after GamesStop. Trading volume has completely slashed following S3 admitting their mistake and publishing corrected numbers. With the thesis for the CLOV squeeze broken, look for this stock to complete H&S as investors inevitably dump the share price once boredom and fear of loss sets in back to the 7.75 range.
Frånsägelse av ansvar

Informationen och publikationerna är inte avsedda att vara, och utgör inte heller finansiella, investerings-, handels- eller andra typer av råd eller rekommendationer som tillhandahålls eller stöds av TradingView. Läs mer i Användarvillkoren.